Isoray Reschedules Fourth Quarter and Fiscal Year End 2021 Financial Results Conference Call to September 22, 2021 Due to Conference Provider Technical Issues

Rhea-AI Summary

Isoray has announced a rescheduled conference call on September 22, 2021, at 10:00 a.m. ET to discuss financial results for the fourth quarter and fiscal year ended June 30, 2021. Initially planned earlier, the call was postponed due to technical issues with the conference bridge provider. The financial results were already released on September 21, 2021, after market close. Investors can access the call by dialing 888-506-0062, or 973-528-0011 for international callers, with a simultaneous webcast available for broader accessibility.

Conference Call Rescheduled for Wednesday, September 22 at 10:00 a.m. ET/7:00 a.m. PT

RICHLAND, Wash., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in brachytherapy powering expanding treatment options throughout the body, will host a rescheduled conference call to discuss its financial results for the fourth quarter and fiscal year ended June 30, 2021 on Wednesday, September 22, 2021, at 10:00 a.m. Eastern Time/7:00 a.m. Pacific.

The rescheduled conference call was necessitated by the conference bridge provider’s technical failure. The Company has already issued a press release announcing its financial results for the fourth quarter and fiscal year ended June 30, 2021. The press release was issued after the close of the U.S. stock markets on September 21, 2021.

To listen to the conference call, please dial 888-506-0062. For callers outside the U.S., please dial 973-528-0011.

The conference call will be simultaneously webcast and can be accessed at   https://www.webcaster4.com/Webcast/Page/2199/42976. The webcast will be available until December 22, 2021 following the conference call.

About Isoray
Isoray, Inc. is a medical technology company pioneering advanced treatment applications and devices to deliver targeted internal radiation treatments for cancers throughout the body. Isoray, Inc., through its subsidiary, Isoray Medical, Inc., is the sole producer of Cesium-131 brachytherapy seeds. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and Twitter.

FAQ

When is Isoray's rescheduled conference call?

Isoray's rescheduled conference call will take place on September 22, 2021, at 10:00 a.m. ET.

What financial results will Isoray discuss during the conference call?

Isoray will discuss its financial results for the fourth quarter and fiscal year ended June 30, 2021.

Why was the Isoray conference call rescheduled?

The conference call was rescheduled due to a technical failure with the conference bridge provider.

How can investors access the Isoray conference call?

Investors can access the conference call by dialing 888-506-0062 or 973-528-0011 for international calls, or they can listen via the webcast.

When was Isoray's financial results press release issued?

Isoray's financial results press release was issued on September 21, 2021, after the close of U.S. stock markets.